|
|
| Line 42: |
Line 42: |
| | </div> | | </div> |
| | </div> | | </div> |
| − | | + | <div class="EndFloatBlock"></div> |
| | </div> | | </div> |
| | | | |
| | | | |
| | | | |
| − | <div class="boxgrid contentBorder boxgridBig" id="box2" style="margin-left:8px">
| |
| − | <img src="">
| |
| − | <a class="cover boxcaption" style="top: 465px" href="https://2014.igem.org/Team:SDU-Denmark/Tour10">
| |
| − | <h2 class="onBlack">PAST is the future</h2>
| |
| − | <p class="onBlackIntro">
| |
| − |
| |
| − |
| |
| − |
| |
| − | For decades aptamers have been known as potential rivals of antibodies. Despite this it seems that many researchers still use traditionally produced monoclonal antibodies. Try out our wiki-tour and discover how we modified Escherichia coli bacteria into a peptide aptamer-producing manufactory by peptide aptamer screening using two-hybrid system (PAST).
| |
| − |
| |
| − | </p>
| |
| − | <p class="onBlack">
| |
| − |
| |
| − | </p>
| |
| − | </a>
| |
| − | </div>
| |
| − | </div>
| |
| − | <div class="EndFloatBlock"></div>
| |
| − | </div>
| |
| | | | |
| | | | |
